Indication
Fungal infection
1 clinical trial
1 product
Product
IbrexafungerpClinical trial
A Phase 1, Open-Label, Single-Centre Study to Evaluate the Absorption, Distribution, Metabolism and Excretion (ADME) of Oral [14^C]-Ibrexafungerp in Healthy Male Subjects After Repeat DosingStatus: Completed, Estimated PCD: 2023-01-28